January 2025
We had a very busy 2024 at Qkine!
- Launching 25 new products, including our first extracellular matrix protein, vitronectin.
- Launching our new high quality food grade growth factor range for use in cellular agriculture.
- Transitioning to a fully animal origin-free manufacturing process for all products.
- Integrating our new fill-finish automation.
- Being recertified with international standard ISO 9001:2015.
- Partnering with new distributors Scientist.com, SLS, Pitagen and our latest, a strategic partnership with REPROCELL.
- Winning ‘Scale-up of the year’ at the Cambridge Independent Business awards.
- Collaborating with some amazing industrial partners including StemCultures, inscreenex and Culturon.
We’re looking forward to what 2025 will bring and would like to wish everyone a very happy and prosperous New Year with our first newsletter of 2025.
Qkine joins forces with Culturon to deliver cutting-edge solutions for the stem cell and life science industries
We are delighted to share that Culturon and Qkine have joined forces to deliver cutting-edge solutions for the stem cell and life science industries.
Culturon, based in Sydney, Australia, specialize in the development of advanced cell culture surfaces that revolutionize cell culture surface engineering to greatly improve performance for stem cell research and manufacturing. Our innovative surfaces enable easy covalent attachment of proteins and biomolecules, providing unparalleled control over the cell culture microenvironment for enhanced reproducibility and outcomes.
Culturon are revolutionizing cell culture plastics, read more about their technology.
Jointly developed products launching in early 2025.
Qkine announces partnership with REPROCELL: Global distributorship for high quality bioactive proteins for stem cell culture
REPROCELL is Japan’s first and leading induced pluripotent stem cell (iPSC) company, and we are delighted to have partnered with them to globally distribute our high-quality proteins such as growth factors and cytokines manufactured by Qkine.
Qkine to exhibit at Advanced Therapies Week 2025: Unlocking Innovation in Dallas
We’re excited to announce that we will be taking part in Advanced Therapies Week 2025, happening from January 20-23, 2025, in Dallas, Texas. This landmark event, which will be held in this vibrant city for one year only, promises to be a must-attend for anyone in the advanced therapies field.
Qkine can’t wait to be part of this extraordinary gathering dedicated to shaping the future of advanced therapies. Be sure to secure your spot and experience the power of collaboration and innovation in Dallas! For more information and to purchase tickets, visit advancedtherapiesweek.phacilitate.com
Qkine will be joining the BIA UK Pavilion, eight pioneering companies chosen to highlight the UK’s strengths in advanced therapies on a global platform.
Qkine supports the launch of the UK Stem Cell Network
There are many active local stem cell networks, however to widen the reach and research impact of the excellent work being undertaken locally, the UK Stem Cell Network (UKSCN) aims to re-establish a national network to serve the UK stem cell community.
Qkine has pledged full support for this endeavour and is a platinum sponsor of the network as well as providing other support and resources. We’re looking forward to attending the inaugural new UKSCN Meeting 16th-17th September 2025 in Manchester, UK.
For more details join the UKSCN LinkedIn group https://lnkd.in/eRR4pPZS.
Qkine strengthens its support for the cellular agriculture through provision of high quality food grade growth factors
We are delighted to announce the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant protein supply chain for emerging sectors.
Our high quality food grade proteins have been featured in the press!
Qkine freeze prices for 2025 in support of stem cell science
In these economically challenging times, Qkine is committed to supporting our customers, and therefore, we have decided to hold current prices into 2025. This will allow customers to continue to budget effectively and help them maximise the impact of innovations utilising stem cell science.
NEW APPLICATION NOTE
Hepatocyte-like cell differentiation using Qkine animal origin-free growth factors
The advancements in iPSC-derived hepatocyte differentiation underscore the potential for combining cutting-edge stem cell technologies with molecular biology to transform research, drug discovery, and regenerative therapies for liver-related conditions. This application note defines a protocol and key considerations for generating HLCs, highlighting the role of specific growth factors in achieving optimal differentiation outcomes.
For HLC differentiation from iPSC this application note uses Qkine recombinant activin A (Qk001), BMP-4 (Qk038), FGF2-G3 (Qk053), HGF NK1 (Qk013) and OSM (Qk049).
Immunocytochemistry of hepatocellular markers in differentiated iPSCs.
PRODUCT SPOTLIGHT – ORGANOIDS
Human activin A protein
Activin A is frequently used to maintain pluripotency in induced pluripotent and embryonic stem cell cultures. It is also used in many stem cell differentiation protocols, including endoderm lineage differentiation and the culture of cardiac and lung organoids.
Qkine activin A (Qk001) has equivalent bioactivity to activin A from an alternative major supplier.
Human noggin protein
Noggin is a bone morphogenetic protein (BMP) antagonist which regulates cell differentiation and growth during embryonic development. Noggin is used in the culture of embryonic and pluripotent stem cells and to derive neural and microglial lineages. It can also be used to generate intestinal, pancreatic, lung, and tumor-derived organoids.
Qkine human noggin (Qk034) has comparable bioactivity to noggin from an alternative major supplier.
All our growth factors are manufactured within a stringent quality framework, ensuring high-quality proteins that maintain robust, reproducible, and physiologically relevant stem cell and organoid cultures that adhere to our Nine-point Quality Commitment.
UPCOMING EVENTS
- Advanced Therapies Week | 20th-23rd January 2025 | Dallas, TX
- Bezos Centre Scientific Kick-Off Event | Imperial College London, UK
- CAOS 2025: Conference on Advancements in Organoid Sciences | 30th-31st January 2025 | Hamburg, Germany
- LSCN Symposium – Organoids in Action: Bridging Developmental Biology and Disease Studies | 5th February 2025 | London, UK
- WORD+ 2025 | 11-12th February 2025 | Cambridge, UK
- 3rd Annual Meat Evolution Leaders Summit (MEVO) 2025 | 12-13th February 2025 | Raffles, Singapore
- Pluripotent Stem Cells: Summit on Setting Standards and Shaping Therapies | 13th February 2025 | Edinburgh, Scotland, UK
- Stem Cell Competition as a Driver of Premalignancy and Cancer | 24th February 2025 | Trumpington, UK
Sign up to hear about the latest in growth factor innovation, new products and cool stem cell science
We respect your time! You will receive update emails only when there is something important to say. Our privacy policy is available here. You can unsubscribe at any time.
